ITMI942166A0 - Composizioni farmaceutiche miorilassanti - Google Patents

Composizioni farmaceutiche miorilassanti

Info

Publication number
ITMI942166A0
ITMI942166A0 ITMI942166A ITMI942166A ITMI942166A0 IT MI942166 A0 ITMI942166 A0 IT MI942166A0 IT MI942166 A ITMI942166 A IT MI942166A IT MI942166 A ITMI942166 A IT MI942166A IT MI942166 A0 ITMI942166 A0 IT MI942166A0
Authority
IT
Italy
Prior art keywords
miorelaxants
pharmaceutical compositions
pharmaceutical
compositions
compositions miorelaxants
Prior art date
Application number
ITMI942166A
Other languages
English (en)
Inventor
Stefano Poli
Tiziano Crimella
Ambrogio Magni
Luigi Moro
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11369756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI942166(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to ITMI942166A priority Critical patent/IT1271031B/it
Publication of ITMI942166A0 publication Critical patent/ITMI942166A0/it
Priority to ES95115576T priority patent/ES2088379T3/es
Priority to DK95115576.1T priority patent/DK0707853T3/da
Priority to DE0707853T priority patent/DE707853T1/de
Priority to AT95115576T priority patent/ATE156016T1/de
Priority to DE69500490T priority patent/DE69500490T2/de
Priority to EP95115576A priority patent/EP0707853B1/en
Priority to CA002160938A priority patent/CA2160938C/en
Priority to US08/586,088 priority patent/US5767112A/en
Publication of ITMI942166A1 publication Critical patent/ITMI942166A1/it
Priority to GR960300039T priority patent/GR960300039T1/el
Publication of IT1271031B publication Critical patent/IT1271031B/it
Application granted granted Critical
Priority to GR970402416T priority patent/GR3024761T3/el
Priority to HK98100704.0A priority patent/HK1001719B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ITMI942166A 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti IT1271031B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti
DK95115576.1T DK0707853T3 (da) 1994-10-21 1995-10-02 Muselrelakserende farmaceutiske præparater
DE69500490T DE69500490T2 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende Arzneizubereitungen
EP95115576A EP0707853B1 (en) 1994-10-21 1995-10-02 Muscle relaxant pharmaceutical compositions
DE0707853T DE707853T1 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende Arzneizubereitungen
AT95115576T ATE156016T1 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende arzneizubereitungen
ES95115576T ES2088379T3 (es) 1994-10-21 1995-10-02 Composiciones farmaceuticas relajantes musculares.
CA002160938A CA2160938C (en) 1994-10-21 1995-10-19 Muscle relaxant pharmaceutical compositions
US08/586,088 US5767112A (en) 1994-10-21 1996-01-16 Muscle relaxant pharmaceutical compositions
GR960300039T GR960300039T1 (en) 1994-10-21 1996-08-31 Muscle relaxant pharmaceutical compositions
GR970402416T GR3024761T3 (en) 1994-10-21 1997-09-17 Muscle relaxant pharmaceutical compositions
HK98100704.0A HK1001719B (en) 1994-10-21 1998-01-27 Muscle relaxant pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti

Publications (3)

Publication Number Publication Date
ITMI942166A0 true ITMI942166A0 (it) 1994-10-21
ITMI942166A1 ITMI942166A1 (it) 1996-04-21
IT1271031B IT1271031B (it) 1997-05-26

Family

ID=11369756

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti

Country Status (8)

Country Link
EP (1) EP0707853B1 (it)
AT (1) ATE156016T1 (it)
CA (1) CA2160938C (it)
DE (2) DE707853T1 (it)
DK (1) DK0707853T3 (it)
ES (1) ES2088379T3 (it)
GR (2) GR960300039T1 (it)
IT (1) IT1271031B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
DK1239884T3 (da) * 1999-12-22 2007-08-06 Glaxo Group Ltd Fremgangsmåder til fremstilling af farmaceutiske formuleringer
DE102005030423A1 (de) * 2005-06-30 2007-01-04 Inresa Arzneimittel Gmbh Neue Formulierung für Vecuroniumbromid
WO2007067784A2 (en) * 2005-12-08 2007-06-14 Wyeth Liposomal compositions
EP2712611A1 (en) 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilized aqueous compositions of neuromuscular blocking agents
RU2594062C2 (ru) * 2013-07-23 2016-08-10 Закрытое акционерное общество "ЭкоФармПлюс" Способ получения фармацевтического состава рокурония бромида в форме стабильного лиофилизата и фармацевтический состав, полученный этим способом
CN107638391B (zh) * 2016-07-22 2020-10-16 海南合瑞制药股份有限公司 一种注射用苯磺顺阿曲库铵组合物
CN108676052B (zh) * 2018-08-16 2020-05-22 北京市新里程医药科技有限公司 一种罗库溴铵的制备方法及其药物组合物
CN111374942B (zh) * 2018-12-30 2022-09-13 鲁南制药集团股份有限公司 一种甾体类肌松药注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2130357A1 (en) * 1992-02-18 1993-08-19 Doron Friedman Dry compositions for preparing submicron emulsions
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity

Also Published As

Publication number Publication date
ATE156016T1 (de) 1997-08-15
DE707853T1 (de) 1996-12-12
DE69500490D1 (de) 1997-09-04
IT1271031B (it) 1997-05-26
DK0707853T3 (da) 1998-03-02
HK1001719A1 (en) 1998-07-03
ES2088379T3 (es) 1997-10-16
CA2160938A1 (en) 1996-04-22
EP0707853A1 (en) 1996-04-24
EP0707853B1 (en) 1997-07-30
ITMI942166A1 (it) 1996-04-21
DE69500490T2 (de) 1997-12-04
GR960300039T1 (en) 1996-08-31
GR3024761T3 (en) 1997-12-31
CA2160938C (en) 2008-07-15
ES2088379T1 (es) 1996-08-16

Similar Documents

Publication Publication Date Title
FI20071025L (fi) Farmaseuttisia koostumuksia
IS4706A (is) Lyfjasamsetningar
NO20004345D0 (no) Farmasøytisk sammensetning
FI965202L (fi) Farmaseuttiset takriinikoostumukset
ID18352A (id) Komposisi-komposisi farmasi
FI991302L (fi) Parannetut farmaseuttiset koostumukset
BR9507768A (pt) Composição farmacêutica
FI943705L (fi) Farmaseuttiset koostumukset
EE9900440A (et) Farmatseutilised kompositsioonid
LV11727A (lv) Farmaceitiska kompozicija
ITMI941169A0 (it) Formulazioni farmaceutiche
PT941100E (pt) Composicoes farmaceuticas
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
EE200000330A (et) Farmatseutilised kompositsioonid
FI973280A7 (fi) Farmaseuttinen koostumus
FI940726L (fi) Farmaseuttiset koostumukset
FI962738A0 (fi) Farmaseuttiset koostumukset
FI954050A7 (fi) Lääkekoostumuksia
ITMI962628A0 (it) Composizione farmaceutica
BR9605777A (pt) Composição farmacêutica
NO994436D0 (no) Farmasöytiske sammensetninger
BR9605131A (pt) Composição farmacêutica
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9402924D0 (sv) Novel pharmaceutical composition
SE9402437D0 (sv) Pharmaceutical composition

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029